Hepatic encephalopathy (HE ... Increasingly, study of the mechanisms responsible for brain swelling provides critical information for understanding the pathogenesis of HE.

In the last decade, significant progress has been made in the understanding of the mechanisms leading to decompensation ... the logical targets for innovative therapies that prevent hepatic ...

Water retention is when fluid builds up in part of your body. It is also called fluid retention or edema. It can affect body tissues outside of blood vessels, leading to swelling or bloating. Water ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

“With rifaximin, one could expect not only improvement in hepatic encephalopathy but also a decreased infection rate, the most common trigger of acute-on-chronic liver failure [ACLF].

New research shows that exercise may protect brain function even when the body can’t produce ketones, a vital energy source ...

Symptoms that are sometimes diagnosed as part of dementia might actually be related to a treatable liver condition, according ...

The target population includes patients with AD or ACLF grade 1 having grades 2, 3, or 4 overt Hepatic Encephalopathy (HE) and ascites as a prerequisite for enrollment. The primary endpoint is ...

In 2024, Iqirvo® received marketing approval in PBC in both the United States and Europe, and was subsequently commercially launched in the U.S. and in some European countries by Ipsen, who reported ...